ADAM Bisaga
Affiliations: | Columbia University, New York, NY |
Area:
addiction, pharmacotherapyGoogle:
"ADAM Bisaga"Mean distance: 53433
Parents
Sign in to add mentorHerbert D. Kleber | research scientist | 1997- | Columbia University Medical School |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Tardelli V, Xu KY, Bisaga A, et al. (2023) Prescription amphetamines in people with opioid use disorder and co-occurring psychostimulant use disorder initiating buprenorphine: an analysis of treatment retention and overdose risk. Bmj Mental Health. 26 |
Greiner MG, Shulman M, Opara O, et al. (2023) Surmounting withdrawal to initiate fast treatment with naltrexone (SWIFT): A stepped wedge hybrid type 1 effectiveness-implementation study. Contemporary Clinical Trials. 128: 107148 |
Williams AR, Aronowitz S, Gallagher R, et al. (2022) A Virtual-First Telehealth Treatment Model for Opioid Use Disorder. Journal of General Internal Medicine |
Shulman M, Hu MC, Sullivan MA, et al. (2022) Patient characteristics associated with initiation of XR-naltrexone for opioid use disorder in clinical trials. Drug and Alcohol Dependence. 233: 109343 |
Levine A, Clemenza K, Weiss S, et al. (2021) Discovering Non-Invasive Biomarkers Predictive of Opioid Use Disorder Treatment Response. Cns Spectrums. 26: 173 |
Levin FR, Mariani JJ, Pavlicova M, et al. (2021) Lorcaserin treatment for extended-release naltrexone induction and retention for opioid use disorder individuals: A pilot, placebo-controlled randomized trial. Drug and Alcohol Dependence. 219: 108482 |
Kidd JD, Smith JL, Hu MC, et al. (2020) Medical Student Attitudes Toward Substance Use Disorders Before and After a Skills-Based Screening, Brief Intervention, and Referral to Treatment (SBIRT) Curriculum. Advances in Medical Education and Practice. 11: 455-461 |
Tardelli VS, Bisaga A, Arcadepani FB, et al. (2020) Prescription psychostimulants for the treatment of stimulant use disorder: a systematic review and meta-analysis. Psychopharmacology |
Nunes EV, Bisaga A, Krupitsky E, et al. (2020) Reply to Kunoe (2020) and Ghosh and Singh (2020) regarding: Nunes et al., Opioid use and dropout from extended-release naltrexone in a controlled trial: implications for mechanism. Addiction. 2020 Feb;115(2):239-246. Addiction (Abingdon, England) |
Ghosh A, Roub F, Bisaga A. (2020) Drug treatment of SARS-Cov2: Potential effects in patients with substance use disorders (SUD). Journal of Psychosomatic Research. 135: 110159 |